Fertility and Sterility
Volume 93, Issue 7 , Pages 2291-2294 , 1 May 2010

Serologic markers of autoimmunity in women with polycystic ovary syndrome

  • Katrin Hefler-Frischmuth, M.D.

      Affiliations

    • Department of Laboratory Medicine, Wilhelminen Hospital Vienna, Vienna, Austria
    • ,
  • Katharina Walch, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria
    • ,
  • Wolfgang Huebl, M.D.

      Affiliations

    • Department of Laboratory Medicine, Wilhelminen Hospital Vienna, Vienna, Austria
    • ,
  • Konstantin Baumuehlner, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria
    • ,
  • Clemens Tempfer, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria
    • ,
  • Lukas Hefler, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria
    • Corresponding Author InformationReprint requests: Lukas Hefler, M.D., Department of Obstetrics and Gynecology, Medical University of Vienna, A-1090 Vienna, Waehringer Gürtel 18-20, Austria (FAX: 43-1-40400-2911).

Received 23 November 2008 ,Revised 5 January 2009 ,Accepted 6 January 2009.

References 

  1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–2438
  2. Knochenhauer ES, Key TJ, Kashar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–3082
  3. Zacur HA. Polycystic ovary syndrome, hyperandrogenism, and insulin resistance. Obstet Gynecol Clin North Am. 2001;28:21–33
  4. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, et al. Formation and early development of follicles in polycystic ovary. Lancet. 2003;362:1017–1021
  5. Forges T, Monnier-Barbarino P, Faure GC, Béné MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004;10:163–175
  6. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocrinol Rev. 1997;18:107–134
  7. Ulukus M, Arici A. Immunology of endometriosis. Minerva Ginecol. 2005;57:237–248
  8. Nakamura RM, Tan EM. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases. Clin Lab Med. 1992;12:1–23
  9. Barland P, Lipstein E. Selection and use of laboratory test in the rheumatic diseases. Am J Med. 1996;100:16S–23S
  10. Isenberg DA, Ravirajan CT, Rahman A, Kalsi J. The role of antibodies to DNA in systemic lupus erythematosus-a review and introduction to an international workshop on DNA antibodies held in London, May 1996. Lupus. 1997;6:290–2304
  11. Hietarinta M, Lassila O. Clinical significance of antinuclear antibodies in systemic rheumatic disease. Ann Med. 1996;28:283–291
  12. Alexander E, Buyon JP, Provost TT, Guarnieri T. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. Arthritis and Rheumatism. 1992;35:176–189
  13. Fritzler MJ. Clinical relevance of autoantibodies in systemic rheumatic diseases. Mol Biol Rep. 1996;23:133–145
  14. Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol. 1990;9:191–207
  15. Lonsdale RN, Roberts PF, Trowell JE. Autoimmune oophoritis associated with polycystic ovaries. Histopathology. 1991;19:77–81
  16. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223–1236
  17. van Gelderen CJ. Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med. 1993;38:381–386
  18. Fénichel P, Gobert B, Carré Y, Barbarino-Monnier P, Hiéronimus S. Polycystic ovary syndrome in autoimmune disease. Lancet. 1999;353:2210
  19. Rojansky N, Roll D, Meirow D. Polycystic ovary syndrome. An autoimmune disease?. J Reprod Med. 1997;42:325–328
  20. Luborsky JL, Shatavi S, Adamczyk P, Chiong C, Llanes B, Lafniztzegger J, et al. Polycystic ovary syndrome and ovarian autoimmunity—assessment of ovarian antibodies by EIA. J Reprod Immunol. 1999;42:79–84
  21. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–1447
  22. Yeh HC, Futterweit W, Thornton JC. Polycystic ovarian disease: US features in 104 patients. Radiology. 1987;163:111–116
  23. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91:2587–2591
  24. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85
  25. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol Med. 2003;9:223–228
  26. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, Tsai CH. Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas. Fertil Steril. 2004;82:1177–1181
  27. Barber HR. Present status of tumor immunology in clinical gynecology. Am J Reprod Immunol. 1989;20:140–146
  28. Haller K, Mathieu C, Rull K, Matt K, Béné MC, Uibo R. IgG, IgA and IgM antibodies against FSH: serological markers of pathogenic autoimmunity or of normal immunoregulation?. Am J Reprod Immunol. 2005;54:262–269
  29. Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gartner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150:363–369
  30. Lee SH, Kim MR, Kim JH, Kwon HS, Yoon KH, Son HY, et al. A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2. Gynecol Endocrinol. 2007;23:252–256
  31. Suh YL. Autoimmune oophoritis—a case report. J Korean Med Sci. 1992;7:284–290
  32. Guzick DS. Ovulation induction management of PCOS. Clin Obstet Gynecol. 2007;50:255–267

 K.H.-F. has nothing to disclose. K.W. has nothing to disclose. W.H. has nothing to disclose. K.B. has nothing to disclose. C.T. has nothing to disclose. L.H. has nothing to disclose.

PII: S0015-0282(09)00044-2

doi: 10.1016/j.fertnstert.2009.01.056

Fertility and Sterility
Volume 93, Issue 7 , Pages 2291-2294 , 1 May 2010

Article Tools